DIAMOX Side Effects

6581705-3 | Blister
on Feb 11, 2010 Female patient from UNITED STATES , weighting 192.0 lb, was diagnosed with benign intracranial hypertension and was treated with Diamox (View Usage). Patient experienced the following unwanted or unexpected effects: blister. Diamox dosage: 500 2 Times/day Oral 1-2 Years Ago.

5940626-7 | Blood Glucose Increased, Glucose Tolerance Impaired, Increased Tendency To Bruise, Paraesthesia, Photopsia
Patient was taking Diamox (View Usage). Patient had the following side effects: blood glucose increased, glucose tolerance impaired, increased tendency to bruise, paraesthesia, photopsia on Nov 03, 2008 from UNITED STATES Additional patient health information: Female patient , 60 years of age, weighting 126.0 lb, . Diamox dosage: .

5892956-5 | Diarrhoea
Adverse event was reported on Sep 22, 2008 by a Female patient taking Diamox (View Usage) (Dosage: 500 Mg Twice Daily Po) was diagnosed with benign intracranial hypertension and. Location: UNITED STATES , 40 years of age, weighting 150.0 lb, After Diamox was administered, patient had the following side effects: diarrhoea.

5844854-0 | Aplasia Pure Red Cell, Cytomegalovirus Antibody Positive, Epstein-barr Virus Antibody Positive, Parvovirus B19 Serology Positive, Thrombocytopenia
on Jul 28, 2008 Male patient from FRANCE , 52 years of age, weighting 154.3 lb, was diagnosed with renal failure chronic and was treated with Diamox (View Usage). Patient experienced the following unwanted or unexpected effects: aplasia pure red cell, cytomegalovirus antibody positive, epstein-barr virus antibody positive, parvovirus b19 serology positive, thrombocytopenia. Diamox dosage: Oral. During the same period patient was treated with ARANESP (80 Ug, 1 In 2 Weeks, Subcutaneous) (View Aranesp Review and Aranesp Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), BRIMONIDINE TARTRATE (View Brimonidine Tartrate Review and Brimonidine Tartrate Label ), CALCIC ATORVASTATINE (View Calcic Atorvastatine Review and Calcic Atorvastatine Label ), CALCIUM CARBONATE (CALCIUM CARBONATE) (View Calcium Carbonate (calcium Carbonate) Review and Calcium Carbonate (calcium Carbonate) Label ), FUROSEMIDE (FUROSEMIDE) (View Furosemide (furosemide) Review and Furosemide (furosemide) Label ), IRBESARTAN (View Irbesartan Review and Irbesartan Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.


5463943-6 | Cholecystitis Chronic, Cholelithiasis, Pain
on Sep 14, 2007 Female patient from UNITED STATES , 32 years of age, weighting 138.7 lb, was treated with Diamox (View Usage). Patient had the following side effects: cholecystitis chronic, cholelithiasis, pain (What is pain?). Diamox dosage: 500 Mg, Single, Oral. Patient was hospitalized.

5455008-4 | Angle Closure Glaucoma, Choroidal Effusion
Patient was taking Diamox (View Usage). After Diamox was administered, patient had the following side effects: angle closure glaucoma, choroidal effusion on Sep 05, 2007 from INDIA Additional patient health information: Male patient , 66 years of age, . Diamox dosage: Oral, 250 Mg, Tid, Oral. During the same period patient was treated with MANNITOL (MANNITOL) INTRAVENOUS (View Mannitol (mannitol) Intravenous Review and Mannitol (mannitol) Intravenous Label ), OFLOXACIN (OFLOXACIN) DROP (View Ofloxacin (ofloxacin) Drop Review and Ofloxacin (ofloxacin) Drop Label ), TIMOLOL (TIMOLOL) DROP (View Timolol (timolol) Drop Review and Timolol (timolol) Drop Label ), DEXAMETHASONE (DEXAMETHASONE) DROP (View Dexamethasone (dexamethasone) Drop Review and Dexamethasone (dexamethasone) Drop Label ). Patient was hospitalized.

5421835-2 | Cholecystitis Chronic, Cholelithiasis
Adverse event was reported on Aug 16, 2007 by a Female patient taking Diamox (View Usage) (Dosage: 500 Mg, Single, Oral) . Location: UNITED STATES , 32 years of age, weighting 138.7 lb, Patient experienced the following unwanted or unexpected effects: cholecystitis chronic, cholelithiasis. Patient was hospitalized.

5409039-0 | Cholecystitis Chronic, Cholelithiasis
on Jul 26, 2007 Female patient from UNITED STATES , 32 years of age, weighting 138.7 lb, was treated with Diamox (View Usage). Patient had the following side effects: cholecystitis chronic, cholelithiasis. Diamox dosage: 500 Mg, Single, Oral. Patient was hospitalized.

5408160-0 | Anuria, Back Pain, Haematuria, No Therapeutic Response, Renal Failure Acute
on Jul 25, 2007 Male patient from SPAIN , 58 years of age, was treated with Diamox (View Usage). After Diamox was administered, patient had the following side effects: anuria, back pain (What is back pain?), haematuria, no therapeutic response, renal failure acute. Diamox dosage: 250 Mg, Q8hr, Oral. Patient was hospitalized.

5407082-9 | Blood Bicarbonate Decreased, Carbon Dioxide Decreased, Condition Aggravated, Coordination Abnormal, Depressed Level Of Consciousness, Dysarthria, Hyperammonaemia, Mental Disorder, Metabolic Acidosis
Patient was taking Diamox (View Usage). Patient experienced the following unwanted or unexpected effects: blood bicarbonate decreased, carbon dioxide decreased, condition aggravated, coordination abnormal, depressed level of consciousness, dysarthria, hyperammonaemia, mental disorder, metabolic acidosis on Jul 18, 2007 from KOREA, DEMOCRATIC PEOPLE'S REPUBLIC OF Additional patient health information: Male patient , 49 years of age, was diagnosed with coordination abnormal, hyperlipidaemia and. Diamox dosage: 250 Mg, Qid. During the same period patient was treated with SIMVASTATIN (40 Mg, Qd, Oral) (View Simvastatin Review and Simvastatin Label ), BENDROFLUAZIDE (BENDROFLUMETHIAZIDE) (View Bendrofluazide (bendroflumethiazide) Review and Bendrofluazide (bendroflumethiazide) Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ). Patient was hospitalized.

5404713-4 | Intraocular Pressure Decreased, Retinal Haemorrhage, Retinopathy
Adverse event was reported on Jul 18, 2007 by a Female patient taking Diamox (View Usage) (Dosage: Intravenous) . Location: UNITED KINGDOM , 65 years of age, Patient had the following side effects: intraocular pressure decreased, retinal haemorrhage, retinopathy. During the same period patient was treated with DEXAMETHASONE TAB (Topical) (View Dexamethasone Tab Review and Dexamethasone Tab Label ), IOPIDINE(APRACLONIDINE) (View Iopidine(apraclonidine) Review and Iopidine(apraclonidine) Label ), PILOCARPINE (View Pilocarpine Review and Pilocarpine Label ). Patient was hospitalized.

5389056-X | Apnoea, Bradycardia, Bronchospasm, Respiratory Rate Increased
on Jul 02, 2007 Male patient from UNITED STATES , weighting 4.41 lb, was treated with Diamox (View Usage). After Diamox was administered, patient had the following side effects: apnoea, bradycardia, bronchospasm, respiratory rate increased. Diamox dosage: 18 Mg, Bid Via Ng Tube, Other. During the same period patient was treated with ALBUTEROL (View Albuterol Review and Albuterol Label ), PULMICORT (View Pulmicort Review and Pulmicort Label ).

5228940-4 | Blood Urine Present, Calculus Bladder
on Jun 12, 2006 Male patient from UNITED STATES , 57 years of age, was diagnosed with glaucoma (What is glaucoma?) and was treated with Diamox (View Usage). Patient experienced the following unwanted or unexpected effects: blood urine present, calculus bladder. Diamox dosage: Oral. During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), LOVASTATIN (View Lovastatin Review and Lovastatin Label ).

5228939-8 | Condition Aggravated, Convulsion
Patient was taking Diamox (View Usage). Patient had the following side effects: condition aggravated, convulsion on Dec 08, 2005 from UNITED STATES Additional patient health information: Female patient , 29 years of age, weighting 110.0 lb, was diagnosed with convulsion and. Diamox dosage: 1 Caps., Bid, Oral. During the same period patient was treated with TEGRETOL (View Tegretol Review and Tegretol Label ), TOPAMAX (View Topamax Review and Topamax Label ).

5004058-0 | Acidosis, Contraindication To Medical Treatment, Growth Retardation
Adverse event was reported on May 15, 2006 by a Female patient taking Diamox (View Usage) (Dosage: 2.5 Ml Three Times A Day Po) was diagnosed with eye disorder and. Location: UNITED STATES , weighting 12.00 lb, After Diamox was administered, patient had the following side effects: acidosis, contraindication to medical treatment, growth retardation.

4936762-4 | Deep Vein Thrombosis, Thrombophlebitis Superficial
on Feb 24, 2006 Female patient from NETHERLANDS , 33 years of age, was diagnosed with mountain sickness acute, prophylaxis and was treated with Diamox (View Usage). Patient experienced the following unwanted or unexpected effects: deep vein thrombosis (What is deep vein thrombosis?), thrombophlebitis superficial. Diamox dosage: . During the same period patient was treated with ORGAMETRIL (LYNESTRENOL) (View Orgametril (lynestrenol) Review and Orgametril (lynestrenol) Label ).

4863139-2 | Aplastic Anaemia
on Jun 08, 2005 Male patient from UNITED STATES , 50 years of age, was treated with Diamox (View Usage). Patient had the following side effects: aplastic anaemia. Diamox dosage: Unk.

4815189-X | Amnesia
Patient was taking Diamox (View Usage). After Diamox was administered, patient had the following side effects: amnesia on Oct 24, 2005 from UNITED STATES Additional patient health information: Male patient , 62 years of age, weighting 200.0 lb, was diagnosed with glaucoma (What is glaucoma?) and. Diamox dosage: . During the same period patient was treated with DEPAKOTE (View Depakote Review and Depakote Label ), FLECAINIDE ACETATE (View Flecainide Acetate Review and Flecainide Acetate Label ), PREVACID (View Prevacid Review and Prevacid Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), EYE DROPS (View Eye Drops Review and Eye Drops Label ).

4805177-1 | Convulsion, Leukaemia, Off Label Use
Adverse event was reported on Sep 19, 2005 by a Male patient taking Diamox (View Usage) (Dosage: 1 Caps., Bid, Oral) was diagnosed with epilepsy (What is epilepsy?) and. Location: UNITED STATES , 48 years of age, weighting 179.9 lb, Patient experienced the following unwanted or unexpected effects: convulsion, leukaemia, off label use. During the same period patient was treated with PHENOBARBITAL TAB (View Phenobarbital Tab Review and Phenobarbital Tab Label ).

4764184-8 | Nephrolithiasis
on Jan 27, 2005 Female patient from UNITED STATES , 47 years of age, weighting 160.1 lb, was diagnosed with epilepsy (What is epilepsy?) and was treated with Diamox (View Usage). Patient had the following side effects: nephrolithiasis. Diamox dosage: 250.00 Mg, Tid, Oral. During the same period patient was treated with LAMICTAL (View Lamictal Review and Lamictal Label ), ZANTAC (View Zantac Review and Zantac Label ), CELEXA (View Celexa Review and Celexa Label ), FELBATOL (View Felbatol Review and Felbatol Label ), PROTONIX (View Protonix Review and Protonix Label ), COQ10 /USA/ (UBIDECARENONE) (View Coq10 /usa/ (ubidecarenone) Review and Coq10 /usa/ (ubidecarenone) Label ), VITAMINS (View Vitamins Review and Vitamins Label ).

4744964-5 | Arteriovenous Malformation, Blood Creatinine Increased, Blood Magnesium Decreased, Blood Potassium Decreased, Blood Urea Increased, Confusional State, Dehydration, Duodenal Ulcer, Gastrointestinal Haemorrhage
on Aug 03, 2005 Female patient from UNITED STATES , 87 years of age, was diagnosed with intraocular pressure decreased, carotid artery occlusion and was treated with Diamox (View Usage). After Diamox was administered, patient had the following side effects: arteriovenous malformation (What is arteriovenous malformation?), blood creatinine increased, blood magnesium decreased, blood potassium decreased, blood urea increased, confusional state, dehydration, duodenal ulcer, gastrointestinal haemorrhage. Diamox dosage: 500.00 Mg, Qd, Oral. During the same period patient was treated with ASPIRIN (E.C.) (ACETYLSALCYLIC ACID) (325.00 Mg, Qd, Oral) (View Aspirin (e.c.) (acetylsalcylic Acid) Review and Aspirin (e.c.) (acetylsalcylic Acid) Label ), COZAAR (View Cozaar Review and Cozaar Label ), TRIAMTERENE AND HYDROCHLOROTHIAZIDE (View Triamterene And Hydrochlorothiazide Review and Triamterene And Hydrochlorothiazide Label ), CENTRUM (VITAMINS NOS, MINERALS NOS) (View Centrum (vitamins Nos, Minerals Nos) Review and Centrum (vitamins Nos, Minerals Nos) Label ), EQUATE ANTACID TABLETS (View Equate Antacid Tablets Review and Equate Antacid Tablets Label ), SINGULAIR (View Singulair Review and Singulair Label ), PAXIL (View Paxil Review and Paxil Label ), LIPITOR (View Lipitor Review and Lipitor Label ). Patient was hospitalized.

4705215-0 | Cardiac Failure Acute, Dizziness, Dyspnoea, Respiratory Arrest
Patient was taking Diamox (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure acute, dizziness (What is dizziness?), dyspnoea, respiratory arrest on Jun 08, 2005 from Additional patient health information: Female patient , 72 years of age, . Diamox dosage: 2 Capsules Oral. During the same period patient was treated with FUROSEMIDE (View Furosemide Review and Furosemide Label ), IRBESARTAN (View Irbesartan Review and Irbesartan Label ). Patient was hospitalized.

4670399-X | Cardiac Arrest, Emphysema, Myocardial Infarction, Procedural Complication
Adverse event was reported on May 03, 2005 by a Male patient taking Diamox (View Usage) (Dosage: 250 Mg 1 X Per 1 Tot) was diagnosed with prophylaxis and. Location: , 82 years of age, Patient had the following side effects: cardiac arrest (What is cardiac arrest?), emphysema, myocardial infarction, procedural complication. During the same period patient was treated with COMBIVENT (View Combivent Review and Combivent Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), SERETIDE (SALMETEROL/FLUTICASONE) (View Seretide (salmeterol/fluticasone) Review and Seretide (salmeterol/fluticasone) Label ).

4620862-2 | Blood Disorder, Condition Aggravated, Glaucoma, Immune System Disorder, Influenza, White Blood Cell Count Decreased
on Mar 15, 2005 Female patient from , 56 years of age, weighting 135.1 lb, was diagnosed with glaucoma (What is glaucoma?) and was treated with Diamox (View Usage). After Diamox was administered, patient had the following side effects: blood disorder, condition aggravated, glaucoma (What is glaucoma?), immune system disorder, influenza, white blood cell count decreased. Diamox dosage: 500 Mg. During the same period patient was treated with NEPTAZANE (View Neptazane Review and Neptazane Label ), PILOCARPINE (PILOCARPINE) (View Pilocarpine (pilocarpine) Review and Pilocarpine (pilocarpine) Label ).

4589400-7 | Blood Disorder, Decreased Immune Responsiveness, Glaucoma, Influenza, White Blood Cell Count Decreased
on Feb 04, 2005 Female patient from , 56 years of age, weighting 134.9 lb, was diagnosed with glaucoma (What is glaucoma?) and was treated with Diamox (View Usage). Patient experienced the following unwanted or unexpected effects: blood disorder, decreased immune responsiveness, glaucoma (What is glaucoma?), influenza, white blood cell count decreased. Diamox dosage: . During the same period patient was treated with NEPTAZANE (METHAZOLAMIDE) (View Neptazane (methazolamide) Review and Neptazane (methazolamide) Label ), PILOCARPINE (PILOCPARPINE) (View Pilocarpine (pilocparpine) Review and Pilocarpine (pilocparpine) Label ).

4576357-8 | Deep Vein Thrombosis, Pulmonary Embolism, Unevaluable Event
Patient was taking Diamox (View Usage). Patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?), pulmonary embolism (What is pulmonary embolism?), unevaluable event on Jan 25, 2005 from Additional patient health information: Male patient , 67 years of age, . Diamox dosage: 250 Mg 1 X Per 1 Day, Oral. Patient was hospitalized.

4568181-7 | Bradycardia, Convulsion, Sinus Tachycardia
Adverse event was reported on Jan 21, 2005 by a Female patient taking Diamox (View Usage) (Dosage: ) was diagnosed with temporal lobe epilepsy and. Location: , 36 years of age, After Diamox was administered, patient had the following side effects: bradycardia, convulsion, sinus tachycardia. During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), CARBAMAZEPINE (View Carbamazepine Review and Carbamazepine Label ), TOPIRAMATE (View Topiramate Review and Topiramate Label ).